Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Tafoxiparin
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Preclinical
Sponsor : Liverpool University
Deal Size : Undisclosed
Deal Type : Collaboration
Details : Liverpool University with Keele University will study Tafoxiparin in order to find an effective treatment of patients who’ve been struck by COVID-19 virus.
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
April 17, 2020
Lead Product(s) : Tafoxiparin
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Preclinical
Sponsor : Liverpool University
Deal Size : Undisclosed
Deal Type : Collaboration